| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2014 | WO2014026078A1 Attenuating or treating sepsis or septic shock |
| 02/13/2014 | WO2014026054A2 CD20 scFv-ELPs METHODS AND THERAPEUTICS |
| 02/13/2014 | WO2014025974A1 Autologous cell-based therapy for treating obesity |
| 02/13/2014 | WO2014025832A1 Wnt modulators for the protection, mitigation and treatment of radiation injury |
| 02/13/2014 | WO2014025771A2 Methods and compositions for inactivating enveloped viruses |
| 02/13/2014 | WO2014025146A1 Composition including c-peptide for preventing or treating diabetic angiogenic disorders |
| 02/13/2014 | WO2014025127A1 Composition containing c-peptide for preventing or treating disorders caused by diabetic vascular leakage |
| 02/13/2014 | WO2014024189A1 Pegylated high affinity leptins with increased biological activity |
| 02/13/2014 | WO2014023976A1 Prophylactic and nutraceutical therapy |
| 02/13/2014 | WO2014023952A2 Prevention and treatment of osteoarthritis |
| 02/13/2014 | WO2014023860A1 Compositions comprising plasma growth factors for use in the treatment of neurodegenerative disorders |
| 02/13/2014 | WO2014023773A1 Use of kgf in the treatment of menopausal disorders |
| 02/13/2014 | WO2014023766A1 Combinations with a backbone-cyclized peptide |
| 02/13/2014 | WO2014023757A1 Combinations with a backbone-cyclized peptide |
| 02/13/2014 | WO2014023752A1 Interleukin-2 fusion proteins and uses thereof |
| 02/13/2014 | WO2014023709A1 Asgpr antibodies and uses thereof |
| 02/13/2014 | WO2014023129A1 α-CONOTOXIN PEPTIDE, AND MEDICAL COMPOSITION AND PURPOSE THEREOF |
| 02/13/2014 | WO2014023007A1 Use of pedf-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis |
| 02/13/2014 | WO2014022947A1 Short polypeptide inhibiting hiv and pharmacal use |
| 02/13/2014 | WO2013186563A3 Factor viii sequences |
| 02/13/2014 | WO2013185134A3 Blood biomarkers for necrotizing enterocolitis |
| 02/13/2014 | WO2013181584A3 Modulation of hepatitis b virus cccdna transcription |
| 02/13/2014 | WO2013181495A3 Compositions comprising an anti-pdgf aptamer and a vegf antagonist |
| 02/13/2014 | WO2013181438A3 Compositions and methods for modulating pro-inflammatory immune response |
| 02/13/2014 | WO2013177596A3 Methods for treating gi syndrome and graft versus host disease |
| 02/13/2014 | WO2013177283A3 Disulfide stabilized foldon polypeptides |
| 02/13/2014 | WO2013080147A3 Anticancer fusion protein |
| 02/13/2014 | US20140047580 Methods and Compositions for Treating Conditions |
| 02/13/2014 | US20140046293 Method Of Drug Delivery For PTH, PTHrP And Related Peptides |
| 02/13/2014 | US20140046292 Method Of Drug Delivery For PTH, PTHrP And Related Peptides |
| 02/13/2014 | US20140046287 Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/13/2014 | US20140046255 Free-standing biodegradable patch |
| 02/13/2014 | US20140046020 Pre-operative use of metabolic activation therapy |
| 02/13/2014 | US20140045923 Gene therapy compositions for preventing and/or treating of autoimmune diseases |
| 02/13/2014 | US20140045916 Splice-region antisense composition and method |
| 02/13/2014 | US20140045907 Use of Inhibitors of the Renin-Angiotensin System |
| 02/13/2014 | US20140045774 Methods for treating viral disorders |
| 02/13/2014 | US20140045773 Ophthalmic compositions and methods for treating eyes |
| 02/13/2014 | US20140045772 Cyclosporin compositions |
| 02/13/2014 | US20140045766 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same |
| 02/13/2014 | US20140045765 Method for inhibiting autophagy of motor neurons |
| 02/13/2014 | US20140045762 Molecular switch for neuronal outgrowth |
| 02/13/2014 | US20140045758 Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock |
| 02/13/2014 | US20140045756 Methods and compositions for modulating tnf/tnfr signaling |
| 02/13/2014 | US20140045755 Methods for treating sleep disorders by cholecystokinin (cck) receptor b antagonists |
| 02/13/2014 | US20140045754 Glp-1 compositions |
| 02/13/2014 | US20140045752 Multicomponent compositions and the uses |
| 02/13/2014 | US20140045750 Methods of protecting against apoptosis using lipopeptides |
| 02/13/2014 | US20140045749 Growth factor complex |
| 02/13/2014 | US20140045748 Composition for Aiding Surgical Procedures for Treating Ischemic Vascular Diseases |
| 02/13/2014 | US20140045747 Methods for increasing and mobilizing hematopoietic stem cells |
| 02/13/2014 | US20140045745 Diketopiperazine microparticles with defined specific surface areas |
| 02/13/2014 | US20140045741 Method Of Treating An Ocular Disease And Compositions Effective For Treating An Ocular Disease |
| 02/13/2014 | US20140045740 Analysis of glatiramer acetate |
| 02/13/2014 | US20140044799 Molecular signature of cutaneous pigmentary spots, associated with the organization of the extracellular matrix |
| 02/13/2014 | US20140044778 NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE |
| 02/13/2014 | US20140044773 Antidotes for factor xa inhibitors and methods of using the same |
| 02/13/2014 | US20140044771 Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof |
| 02/13/2014 | US20140044770 Compositions and Methods for Modulating BRD4 Bioactivity |
| 02/13/2014 | US20140044759 Drug substances, pharmaceutical compositions and methods for preparing the same |
| 02/13/2014 | US20140044754 Tdf-related compounds and analogs thereof |
| 02/13/2014 | US20140044741 B-type plexin antagonists and uses thereof |
| 02/13/2014 | US20140044736 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases |
| 02/13/2014 | US20140044717 Lyophilized formulations |
| 02/13/2014 | US20140044713 Compounds |
| 02/13/2014 | US20140044700 Methods and compositions for improving growth of meat-type poultry |
| 02/13/2014 | US20140044697 Methods for treating lysosomal acid lipase deficiency |
| 02/13/2014 | US20140044695 Botulinum toxin compositions |
| 02/13/2014 | US20140044694 Pharmaceutical composition for treating lysosomal storage disease |
| 02/13/2014 | US20140044689 Methods and compositions for preventing or treating ophthalmic conditions |
| 02/13/2014 | US20140044652 Methods and Related Systems for Selecting or Customizing a Topical Treatment Regimen for a Mammalian Keratinized Surface |
| 02/13/2014 | US20140044644 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
| 02/12/2014 | EP2696203A2 Tumor cell-derived microvesicles |
| 02/12/2014 | EP2695947A1 Recombinant polypeptide production method |
| 02/12/2014 | EP2695895A1 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides |
| 02/12/2014 | EP2695891A1 Octapeptide, radiopharmaceutical agent based thereon and method for diagnosing tumors |
| 02/12/2014 | EP2695620A1 Caprylate viral deactivation |
| 02/12/2014 | EP2695610A1 Food supplement for improving connective tissue health |
| 02/12/2014 | EP2695607A1 Method for producing endoplasmic reticulum |
| 02/12/2014 | EP2694979A1 Tam receptor ligands, metabolites and precursors thereof in the detection and modulation of inflammatory neuropathological disease |
| 02/12/2014 | EP2694538A1 Therapeutic and prophylactic methods, uses and compositions comprising anexin a5 |
| 02/12/2014 | EP2694532A1 Aureobasidium derivatives and methods of synthesis |
| 02/12/2014 | EP2694530A1 Novel peptides that bind to types of mhc class ii and their use on diagnosis and treatment |
| 02/12/2014 | EP2694113A2 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
| 02/12/2014 | EP2694102A2 Methods of improving vaccine immunogenicity |
| 02/12/2014 | EP2694098A1 Oral enzyme compositions for intestinal delivery |
| 02/12/2014 | EP2694097A1 Peptides for suppressing inflammation reactions in hemodialysis |
| 02/12/2014 | EP2694096A1 Melanocyte-stimulation hormone for suppressing inflammation reactions in hemodialysis |
| 02/12/2014 | EP2694095A1 Compositions comprising glucagon analogs and methods of making and using the same |
| 02/12/2014 | EP2694094A1 Method for treating ifnalpha related conditions |
| 02/12/2014 | EP2694093A2 Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy |
| 02/12/2014 | EP2694092A2 Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15) |
| 02/12/2014 | EP2694091A2 Method for the generation of compact tale-nucleases and uses thereof |
| 02/12/2014 | EP2694090A1 Drug containing recombinant mistletoe lectins for treating malignant melanoma |
| 02/12/2014 | EP2694089A1 New tale-protein scaffolds and uses thereof |
| 02/12/2014 | EP2694088A1 Macrophage activating factor for pharmaceutical compositions |
| 02/12/2014 | EP2694087A1 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases |
| 02/12/2014 | EP2694086A1 Mhc engagement and clip modulation for the treatment of disease |
| 02/12/2014 | EP2694085A1 Methods of eradicating bacterial cell populations |
| 02/12/2014 | EP2694084A1 Bpi and its congeners as radiation mitigators and radiation protectors |